Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Other Operating Expenses (2025)

CG Oncology (CGON) has disclosed Other Operating Expenses for 1 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to $3.1 million, compared with a TTM value of $4.6 million through Dec 2025, changed N/A, and an annual FY2025 reading of $4.6 million, changed N/A over the prior year.
  • Other Operating Expenses was $3.1 million for Q4 2025 at CG Oncology, up from $1.6 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $3.1 million in Q4 2025 and bottomed at $1.6 million in Q3 2025.